Forty intensive care unit patients requiring cardiopulmonary resuscitation were randomised to receive either the standard dose of adrenaline (J mg every five minutes) or high-dose adrenaline (10 mg every five minutes). In the majority of patients, overwhelming sepsis was the major contributing factor leading to cardiac arrest. In this group of patients no difference could be detected in response to high-dose adrenaline compared with the standard dose. Although no side-effects were noted with this high dose of adrenaline, more investigation is required prior to its routine use in cardiopulmonary resuscitation.
For many years a dose of 1 mg adrenaline has been administered at varying time intervals during cardiopulmonary resuscitation (CPR) in adults. Recently, the American Heart Association recommended that this dose, repeated every five minutes if no response, be used for all adults. I In animal studies 25 it has been found that higher doses, on a weight basis, were required to restore and maintain diastolic blood pressure, which is a significant prognosticator of survival after cardiac arrest in animals 6 and humans. 7 In addition, animal studies showed that the early administration of alpha receptor agonists improved survival from cardiac arrest. 2, 810 Reports are now appearing in the literature that greater success can be achieved in human CPR with doses of more than 1 mg of adrenaline. 11 16 Our hypothesis was that improved outcome, in the clinical setting of in-hospital CPR, would result from the early administration of a higher dose of adrenaline. This would result from a more consistent return to spontaneous cardiac rhythm and sustained improvement in diastolic blood pressure.
We therefore undertook a randomised, double-blind, controlled study comparing 10 mg versus 1 mg adrenaline, given every five minutes during CPR in our adult intensive care unit (ICU). Other standard CPR protocols remained unchanged.
PATIENTS AND METHODS
Hospital and University Ethics Committee approval for the trial was obtained. In a sterile environment, either 1 ampoule of standard 1 mg (l m!) adrenaline tartrate or 10 ampoules were transferred into prepared 10 ml amber ampoules. The ampoules containing 1 mg (l ml) were filled to 10 ml with 9 ml sterile 0.9070 sodium chloride. All new 10 ml ampoules were sealed by smelting and labelled, depending on their content, either drug A or B. The ampoules were identical and the code was only broken at the end of the trial.
The study was carried out in the adult part of the multi disciplinary lCU attached to Baragwanath Hospital. The hospital is a community-based, tertiary referral hospital of 3000 beds, affiliated with the University of the Witwatersrand. The lCU is a 24-bed unit that serves paediatrics, medicine, surgery and obstetrics and gynaecology. It admits over 500 adult patients per year. Most of our patients (40070) have mainly infective problems with only about 3070 having ischaemic heart disease.
From July 1990 to June 1991, all adult patients requiring CPR, with a witnessed asystolic cardiac arrest, were entered into the study. Asystole was diagnosed from routine, continuous ECG monitoring. The standard CPR protocol in the unit includes cardiac compression, assisted ventilation, sodium bicarbonate and atropine, as clinically indicated. No calcium is used unless there is documented hypocalcaemia or calcium channel blocker overdose. I The time of arrest, response time, time to spontaneous rhythm (SR), other drugs administered, blood pressure post resuscitation and all procedures performed were documented. All patients were randomised, using a computer generated randomisation code, to receive either drug A or drug B, which was given at time zero. The same adrenaline was repeated at five minutes and 10 minutes if spontaneous rhythm had not returned. If after three doses of the trial drug, SR had not returned, standard doses of adrenaline (1 mg) were administered, if deemed necessary. Once SR had returned, blood pressure and pulse were recorded for 20 minutes.
Patient records were analysed for primary diagnosis, admission Apache 11 17 acute physiological score 24 hours prior to arrest, contributing factors to arrest, use of inotropic agents, outcome of arrest and overall survival.
The Student's Hest of independent variables and the chi-squared test were used to analyse the results. A P value of less than 0.05 was considered significant. All results are expressed as mean ± SEM. 
Age Male/Female Days in ICU Apache II

RESULTS
Forty patients were entered into the study. Three had to be excluded due to incomplete records and two due to incorrect entry criteria (respiratory arrest). The acute physiological score, 24 hours prior to arrest, was significantly higher in high-dose group (HDG) compared with the standard-dose group (SDG) ( Table 1) . The degree of inotropic support used also varied between the two groups, there being significantly more dobutamine in the HDG (Table 2 ). There was no other significant difference in demographic data.
The cause of cardiac arrest in the vast majority of patients (80070) was overwhelming sepsis. In the HDG, 17 (89070) had severe sepsis compared with 15 (94070) in the SDG.
There was no significant difference in the response rate between the two groups. Of the 19 patients who received high-dose adrenaline, 15 (68070) were successfully resuscitated compared with 11 (66070) out of the 16 who received the standard dose. None of the other parameters measured were significantly different (Table   3 ).
There was no significant difference in systolic or diastolic blood pressure after resuscitation (Table 4 ).
Of the 19 HDG patients 15 (68070) were resuscitated, five (26070) survived 12 hours, four (21070) survived 24 hours and none was discharged from ICU compared with the SDG in whom 11 (68070) were resuscitated, six (37070) survived 12 hours, five (31070) survived 24 hours and one was discharged from the unit alive. This difference did not reach statistical significance. 
DISCUSSION
Although Ornato 18 has recommended caution before routine use of high-dose adrenaline, a number of other recent editorials 1922 and extensive reviews on adrenaline in adult CPR 23.24 have all suggested that the standard 1 mg dose of adrenaline is insufficient. They base these arguments largely on animal and human data. 25 .1115 Most of the human data comes from case reports 11.12.15 or using historic controls. 14 In addition most of these studies are in paediatric patients. 12.14.15 We could find only one prospective, comparative study using a higher dose of adrenaline (5 mg vs 1 mg) in human CPR. 16 This study, like ours, administered adrenaline early in CPR. The 5 mg dose of adrenaline did produce higher initial resuscitation rates, but hospital discharge rates did not differ. This study, in contrast to ours, was carried out in prehospital asystole or electromechanical dissociation.
In our unit disease profiles differ between paediatric and adult patients. Our paediatric patients have primarily single organ disease, whereas our adults primarily have multi-organ disease and multi-organ failure. Our average adult admission Apache II score is 18 with a predicted mortality of 30070. 17 The adult patients entered into the trial had an average Apache II score of 20 with a predicted mortality of 45%.
All patients had CPR commenced within two minutes of the witnessed arrest. We could find no difference on analysis of the groups and initial survival did not differ. The variation in the acute physiological score between the two groups is of some concern. This difference and the differing use of inotropic agents prior to arrest does complicate the comparison and may be a reason for not showing any significant difference in outcome between the two groups.
Only one patient was discharged from the ICU alive. This one patient was not septic but had severe left ventricular dysfunction due to cardiomyopathic dilatation. The patient was resuscitated for ten minutes and was in ICU for 34 days. He was subsequently discharged from hospital but was lost to follow-up.
A second resuscitation was performed in only one of the patients who responded to the initial attempt. The majority of the patients died subsequently due to progressive sepsis with multiple organ failure.
Most of the patients in this study had severe sepsis with a predicted mortality of 45%.17 Cardiac arrest in this situation is probably a manifestation of a severely diseased myocardium. We think that this accounts for the difference in response rate between the study by Linder et al 16 and our study. Other studies confirm the almost uniformly poor outcome from cardiac arrest in sepsis. 25,26,2R30 This may be partially due to the myocardial depression which occurs in sepsis. Jl32 It may also be related to decreased vascular responsiveness to catecholamine which has been shown, experimentally, to occur in the presence of endotoxin. JJ·J4 We have shown that 10 mg is no better than 1 mg per dose in these patients. Neither the standard nor the high dose of adrenaline, in this group, was of any value. If either the myocardial depression of sepsis or the effect of endotoxin on vascular responsiveness is important in the adult, septic patient who has a cardiac arrest, then even a higher dose than 10 mg every five minutes may be more appropriate during CPR.
A further possible reason for not showing a significant difference in response between the two groups of patients might have been the greater use of inotropic agents in the high dose group prior to CPR. All inotropic agents probably result in a down-regulation of beta adrenergic receptors J5J7 which may account for the poor response rate in this group of patients. It must, however, be noted that all the work to date has been on beta receptors. To the best of our knowledge there is no work on the down-regulation of alpha receptors in humans. Although the activity of adrenaline in CPR depends largely on alpha agonist activity. 10 the down-regulation of receptors may be further rationale for the use of even higher doses of adrenaline in septic patients, on inotropic agents, requiring CPR.
No difference in adverse effects was seen between the two groups. Notably, the high-dose adrenaline group did not show resistant ventricular fibrillation. As we cannot draw conclusions for CPR in all patients we suggest that a similar double-blind randomised study be carried out in pre-hospital arrests or in patients with arrests due to hypovolaemia or ischaemia.
Another limitation of our study was the lack of differentiation between fine ventricular fibrillation and asystole. We diagnosed asystolic cardiac arrest when the patient had no detectable pulse with a straight line on one ECG lead, as this is the clinical setting in which we work. We felt that to change leads in order to differentiate fine ventricular fibrillation from asystole would be detrimental to ultimate outcome. We do not practise CPR on all patients, having a "do not resuscitate" (DNR) protocol for certain cases. We do not feel this has changed the results as the patients in whom DNR was ordered were not entered into the study. In light of the uniformly poor outcome of CPR in asystolic arrest in septic patients the appropriateness of resuscitative attempts in this situation needs to be reviewed.
In conclusion, this is the first double-blind, randomised trial comparing high-dose (10 mg) adrenaline, every five minutes, to the standard dose (l mg) adrenaline, every five minutes, in in-hospital witnessed cardiac arrests in adult patients. In our population group of mainly septic patients, we could find no benefit in using 10 mg doses of adrenaline for CPR. Although no benefit was demonstrated in using the high-dose adrenaline, it produced no resistant ventricular fibrillation that was not present prior to injection of the drug. We therefore suggest that this dose of adrenaline be investigated in other groups of patients needing CPR. Even higher doses of adrenaline may be necessary for a better response to CPR in this group of patients, particularly if they are receiving high doses of inotropes prior to cardiac arrest.
B. Pollard. Palliative Care. In Anaesthesia and Intensive Care 1993; Volume 21, Number 1:97-100. Page 98, paragraph 2, sentence 5 should read "Pain and suffering co-exist when pain is severe and unremitting, when its cause or meaning are not understood, when its cause is dreaded, when nobody is interested enough, or when the pain is thought to be unrelievable."
